Related News
Cheaper cholera vaccine developed
SCIENTISTS have developed a new cholera vaccine that could give poor populations cheaper protection against the disease, an international health agency said yesterday.
Cholera, an acute intestinal infection caused by contaminated food or water, remains a major health problem in the developing world and kills about 120,000 people a year.
But the only internationally licensed vaccine available is far too expensive for most people in such nations, costing about US$18 for a dose in Bangladesh, according to the Seoul-based International Vaccine Institute. Two other cholera vaccines exist but are not as widely available.
The International Vaccine Institute, established in 1997 under a United Nations initiative, announced that its scientists have developed a new oral vaccine that will be available for about US$1 a dose.
"Cholera is a disease of the very poorest people in the world," IVI Director-General John Clemens said. "And if a cholera vaccine is to be used, it has to be made affordable. It's absolutely imperative that the cost be brought down as low as possible."
India's health agency has approved the new oral vaccine, expected to be mass-produced by an Indian company later this month, IVI said. It "paves the way for a wider use of the vaccine in cholera-epidemic populations" once the World Health Organization approves it, Clemens said, adding that the institute hopes the approval will come later this year.
Cholera, an acute intestinal infection caused by contaminated food or water, remains a major health problem in the developing world and kills about 120,000 people a year.
But the only internationally licensed vaccine available is far too expensive for most people in such nations, costing about US$18 for a dose in Bangladesh, according to the Seoul-based International Vaccine Institute. Two other cholera vaccines exist but are not as widely available.
The International Vaccine Institute, established in 1997 under a United Nations initiative, announced that its scientists have developed a new oral vaccine that will be available for about US$1 a dose.
"Cholera is a disease of the very poorest people in the world," IVI Director-General John Clemens said. "And if a cholera vaccine is to be used, it has to be made affordable. It's absolutely imperative that the cost be brought down as low as possible."
India's health agency has approved the new oral vaccine, expected to be mass-produced by an Indian company later this month, IVI said. It "paves the way for a wider use of the vaccine in cholera-epidemic populations" once the World Health Organization approves it, Clemens said, adding that the institute hopes the approval will come later this year.
- About Us
- |
- Terms of Use
- |
- RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.